Bind Therapeutics ends cancer drug partnership with Amgen
July 02, 2014 at 17:55 PM EDT
July 2 (Reuters) - Drug developer Bind Therapeutics said it ended a partnership with Amgen Inc to develop targeted cancer therapy due to unsatisfactory results.
